Login to Your Account

AM-Pharma Returns to Clinic with Kidney Injury Drug

By Nuala Moran
Staff Writer

Friday, September 20, 2013
LONDON – Two years after halting development of bovine alkaline phosphatase, AM-Pharma is back in the clinic with its new, proprietary, recombinant human version of the anti-inflammatory enzyme.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription